Denosumab Subcutaneous and Lenvima
Determining the interaction of Denosumab Subcutaneous and Lenvima and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denosumab
Brand name: Prolia, Xgeva
Synonyms: Denosumab
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denosumab Subcutaneous-Lenvima (14 MG Daily Dose)
- Denosumab Subcutaneous-Lenvima (18 MG Daily Dose)
- Denosumab Subcutaneous-Lenvima (20 MG Daily Dose)
- Denosumab Subcutaneous-Lenvima (24 MG Daily Dose)
- Denosumab Subcutaneous-Lenvima (8 MG Daily Dose)
- Denosumab Subcutaneous-Lenvima 10 MG Daily Dose
- Lenvima-Denovo
- Lenvima-Dent-O-Kain/20
- Lenvima-Denti-Care Denti-Freeze Topical Anesthetic
- Lenvima-DentiPatch
- Lenvima-Deoxycholic acid
- Lenvima-Deoxycholic acid Subcutaneous